Nephros (NEPH) Net Income Growth (1y) (2011 - 2026)
Nephros (NEPH) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.02 Bn | 120.80 Bn | 1.96 Bn | 23.94% |
| 2 | Becton Dickinson | 44.98 Bn | 44.16 Bn | 2.15 Bn | -282.67% |
| 3 | Alcon | 33.07 Bn | 31.41 Bn | 1.53 Bn | - |
| 4 | Medline | 33.03 Bn | 30.80 Bn | 1.84 Bn | -25.78% |
| 5 | Resmed | 29.47 Bn | 27.81 Bn | 890.98 Mn | 9.23% |
| 6 | West Pharmaceutical Services | 23.28 Bn | 22.84 Bn | 329.20 Mn | 16.64% |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | -90.51% |
| 8 | Cooper Companies | 13.93 Bn | 13.79 Bn | 735.40 Mn | -188.83% |
| 9 | Align Technology | 12.10 Bn | 11.04 Bn | 736.59 Mn | 20.96% |
| 10 | Nephros | 36.43 Mn | 32.41 Mn | 2.99 Mn | 103.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.23% |
| Dec 31, 2025 | -82.97% |
| Sep 30, 2025 | 84.15% |
| Jun 30, 2025 | 182.01% |
| Mar 31, 2025 | -332.21% |
| Dec 31, 2024 | 182.73% |
| Sep 30, 2024 | 117.72% |
| Jun 30, 2024 | 51.02% |
| Mar 31, 2024 | 54.98% |
| Dec 31, 2023 | -241.09% |
| Sep 30, 2023 | -102.95% |
| Jun 30, 2023 | -51.28% |
| Mar 31, 2023 | -13.79% |
| Dec 31, 2022 | 59.31% |
| Sep 30, 2022 | -41.39% |
| Jun 30, 2022 | 66.20% |
| Mar 31, 2022 | 60.51% |
| Dec 31, 2021 | 56.52% |
| Sep 30, 2021 | 62.54% |
| Jun 30, 2021 | 29.03% |